- Home
- ONEG vs ENZ Comparison
ONEG vs ENZ Comparison
Compare ONEG & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEG
- ENZ
- Stock Information
- Founded
- ONEG 2021
- ENZ 1976
- Country
- ONEG Hong Kong
- ENZ United States
- Employees
- ONEG N/A
- ENZ N/A
- Industry
- ONEG Homebuilding
- ENZ Medical Specialities
- Sector
- ONEG Consumer Discretionary
- ENZ Health Care
- Exchange
- ONEG Nasdaq
- ENZ Nasdaq
- Market Cap
- ONEG 38.2M
- ENZ 34.2M
- IPO Year
- ONEG 2024
- ENZ N/A
- Fundamental
- Price
- ONEG $3.18
- ENZ $0.43
- Analyst Decision
- ONEG
- ENZ
- Analyst Count
- ONEG 0
- ENZ 0
- Target Price
- ONEG N/A
- ENZ N/A
- AVG Volume (30 Days)
- ONEG 24.6K
- ENZ 93.3K
- Earning Date
- ONEG 01-01-0001
- ENZ 03-17-2025
- Dividend Yield
- ONEG N/A
- ENZ 23.19%
- EPS Growth
- ONEG N/A
- ENZ N/A
- EPS
- ONEG 0.16
- ENZ N/A
- Revenue
- ONEG $63,463,000.00
- ENZ $29,094,000.00
- Revenue This Year
- ONEG N/A
- ENZ N/A
- Revenue Next Year
- ONEG N/A
- ENZ N/A
- P/E Ratio
- ONEG $20.22
- ENZ N/A
- Revenue Growth
- ONEG 16.46
- ENZ N/A
- 52 Week Low
- ONEG $1.96
- ENZ $0.41
- 52 Week High
- ONEG $4.05
- ENZ $1.30
- Technical
- Relative Strength Index (RSI)
- ONEG N/A
- ENZ 33.67
- Support Level
- ONEG N/A
- ENZ $0.42
- Resistance Level
- ONEG N/A
- ENZ $0.50
- Average True Range (ATR)
- ONEG 0.00
- ENZ 0.04
- MACD
- ONEG 0.00
- ENZ 0.00
- Stochastic Oscillator
- ONEG 0.00
- ENZ 10.27
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. It is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project include performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.